Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Zohar Etzioni

Post-doctoral Fellow

Research interests

Somatic mutations are crucial in tumorigenesis and offer avenues for non-invasive cancer detection. Liquid biopsy is transforming cancer care by facilitating the non-invasive identification and monitoring of circulating tumour DNA (ctDNA) in plasma. Recently, there has been an increased focus in detecting ctDNA mutations in situations with low tumour fractions, such as assessing therapeutic responses or gauging minimal residual disease (MRD). My research centres on employing methylation data (TAPS sequencing) to monitor minimal residual disease and early cancer diagnosis using deep learning. Additionally, I have a keen interest in mutational signatures and the algorithms used to extract them.


I completed my PhD in Computer Science at Trinity College Dublin 2011. After that I’ve worked for 10 years in algorithmic trading and decentralised finance. I’ve always had keen interest in computational cancer research and immunology and finally in 2022 I joined Ben Schuster-Böckler's lab.